Listed by the USPTO as CHIN, CHRISTOPHER L
Tech Center 1600 • Art Units: 1641 1674 1677
This examiner grants 81% of resolved cases
CHIN, CHRISTOPHER L works in tech center 1600 and art unit 1641, with 716 resolved cases. The allowance rate is 80.7%, and the median time to allowance is 1347 days. The interview lift is 22.4%, supporting interviews as a useful part of prosecution despite the extended median timeline.
The companies represented are Regeneron Pharmaceuticals Inc., Amgen Inc., and Technion Research & Development Foundation Limited. The leading firms are Knobbe, Martens, Olson & Bear, LLP, ARENTFOX SCHIFF LLP, and Brown Rudnick LLP. Practitioners should pair favorable allowance expectations with careful management of prosecution duration.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18329748 | MAGNETIC PARTICLE AND PARTICLE FOR IMMUNOLOGICAL TEST | Final Rejection | CANON KABUSHIKI KAISHA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy80.7% of resolved applications examined by Christopher L Chin were allowed (716 resolved cases), compared with 45.2% across Art Unit 1641 over the last five years.
This examiner's interview lift is +22.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Christopher L Chin took 1,347 days on average from filing to allowance.
Christopher L Chin examines applications in Art Unit 1641 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
